Edwards Lifesciences said its second-quarter profit surged amid continued sales growth for the company's nonsurgical heart valves as well as a big one-time settlement-related gain.
from WSJ.com: US Business http://ift.tt/1toZHip
via IFTTT
from WSJ.com: US Business http://ift.tt/1toZHip
via IFTTT
No comments:
Post a Comment